News - TreeFrog Therapeutics I iPS-derived cell therapies

Umoja Biopharma and TreeFrog Therapeutics announce collaboration to address current challenges facing ex vivo allogeneic therapies in immuno-oncology

Partnership combines Umoja’s technologies in gene-edited iPSCs and immune differentiation for persistent anti-tumor activity with TreeFrog Therapeutics’ biomimetic platform for the mass-production of iPSC-derived cell therapies in large-scale bioreactors. SEATTLE and PESSAC, France / June 10th, 2022 – Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf,...

10 June, 2022

Applications for the Stem Cell SpaceShot Grant Now Open!

https://youtu.be/w1OQqy26lvU The application form is now online, and will be available until June 30th ! Apply Now ! ...

01 May, 2022

TreeFrog Therapeutics launches a $100,000 research grant in regenerative medicine

Bordeaux, France / April 19th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in...

19 April, 2022

TreeFrog Therapeutics expands Board with new independent members from the cell therapy industry

TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and...

14 April, 2022

treefrog therapeutics kk japan kobe fbri

TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies

08 April, 2022

Scientific advisory board TreeFrog Therapeutics

TreeFrog Therapeutics appoints Scientific Advisory Board to guide the development of proprietary iPS platform & cell therapy pipeline

01 March, 2022

TreeFrog Therapeutics de retour dans le FrenchTech120

TreeFrog Therapeutics back in the FrenchTech120

The whole team at TreeFrog Therapeutics wishes you a Happy New Year !...

01 February, 2022

Happy 2022 from the Froggies (showcasing our egg/chicken/dino dance moves) !

The whole team at TreeFrog Therapeutics wishes you a Happy New Year !...

21 December, 2021

TreeFrog celebrates its third birthday, announcing a two-fold increase in lab capacity !

TreeFrog Therapeutics celebrated its 3rd anniversary on December 7th, 2021, announcing that the company increase its clean room capacity by two-fold in Pessac, to support its acceleration in cell therapy....

07 December, 2021

TreeFrog Therapeutics Awarded the Galien MedStartup Prize 2020 for its International Consortium on iPSC Quality with US, Japan & France

October 28th 2021, Anthony Renodon, U.S. representative of TreeFrog Therapeutics received The Prix Galien MedStartUp 2020 in New York. Awarded on October 26th 2020 to the French cell therapy biotech TreeFrog Therapeutics in the category “Biopharmaceutical Industry” in Boston Organized by the prestigious Galien Foundation and Business...

28 October, 2021

FR / EN / JP